Proteome-Wide Changes in Blood Biomarkers During Hemodialysis

Kidney Int Rep. 2023 Nov 2;9(1):177-181. doi: 10.1016/j.ekir.2023.10.020. eCollection 2024 Jan.

Matthew B Lanktree^{1

2

3}, David Collister⁴, Marie Pigyere^{1

5}, Andrea Mazzetti^{1

2}, Guillaume Paré^{1

3

6}, Michael Walsh^{1

2

3}

¹ Population Health Research Institute, Hamilton, Ontario, Canada.
² Division of Nephrology, Department of Medicine, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
³ Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
⁴ Division of Nephrology, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
⁵ Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
⁶ Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.

No abstract available

Keywords: biomarkers; cardiovascular disease; dialysis; intradialytic hypotension; kidney failure; proteomics.